NCT07254221 2025-12-10
ROSUBREAST
Shiraz University of Medical Sciences
Phase 4 Not yet recruiting
Clinical Trials
5 trialsNCT05338723 2024-02-28
Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients
Tanta University
Phase 3 Completed
NCT01299038 2020-02-05
Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
NCT01051401 2018-08-01
Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer
Wake Forest University Health Sciences
Phase 1 Terminated
NCT02483871 2017-06-05
Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy
Duke University
Phase 1 Withdrawn